4.5 Article

Nonalcoholic fatty liver disease and risk of intracerebral hemorrhage

Journal

NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES
Volume 32, Issue 11, Pages 2561-2567

Publisher

ELSEVIER SCI LTD
DOI: 10.1016/j.numecd.2022.08.010

Keywords

Nonalcoholic fatty liver disease; Intracerebral hemorrhage; Risk; Epidemiology

Funding

  1. Chinese Academy of Medical Sciences Innovation Fund for Medical Sciences [2019-I2M-5-029]
  2. Beijing Municipal Committee of Science and Technology [Z201100005620010]
  3. Beijing Natural Science Foundation [Z200016]
  4. Beijing Hospitals Authority Innovation Studio of Young Staff [202112]

Ask authors/readers for more resources

This study aimed to investigate the association between the severity of nonalcoholic fatty liver disease (NAFLD) steatosis and the risk of future intracerebral hemorrhage (ICH). The results showed that persistent moderate steatosis was significantly associated with an increased risk of future ICH, independent of other conventional risk factors.
Background and aims: This study aimed to investigate the association between the steatosis severity of nonalcoholic fatty liver disease (NAFLD) and future intracerebral hemorrhage (ICH) risk. Methods and results: We used data from the Kailuan study. Participants without a history of stroke, myocardial infarction, cancer, other liver diseases or alcohol abuse were enrolled. NAFLD and the severity of liver steatosis were assessed by abdominal ultrasonography. We stratified the participants into different groups according to the severity changes in liver steatosis status across the first 4-year follow-up period. The outcome was the first occurrence of ICH during the next 6 -year follow-up period. Hazard ratios (HRs) and 95% CI of ICH were estimated using Cox models adjusted for potential risk factors. A total of 49,906 participants were enrolled in this study. Dur-ing a median of 6.79 years of follow-up, 193 incident ICH cases were identified. Compared with persistent nonfatty liver participants, the hazard ratios (HRs) for participants with persistent mild steatosis, persistent moderate steatosis, persistent severe steatosis, alleviating steatosis, and aggravating steatosis were 1.28 (95% CI, 0.75-2.18), 2.33 (95% CI, 1.24-4.38), 1.63 (95% CI, 0.22-12.11), 1.41 (95% CI, 0.91-2.18), and 1.37 (95% CI, 0.94-2.00), respectively, in the fully adjusted model. Conclusions: NAFLD with persistent moderate steatosis was significantly related to an increased risk of future ICH, independent of other conventional risk factors.(c) 2022 The Authors. Published by Elsevier B.V. on behalf of The Italian Diabetes Society, the Ital-ian Society for the Study of Atherosclerosis, the Italian Society of Human Nutrition and the Department of Clinical Medicine and Surgery, Federico II University. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available